Navigation Links
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
Date:5/2/2013

tigation Reform Act of 1995, including, but not limited to, statements concerning our anticipated product development activities, such as expected clinical trial completion and design and statements regarding the potential benefits and potential development of our product candidates. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including, among others, the risk that our product candidates will not demonstrate the hypothesized or expected benefits, the risk of delays in our expected clinical trials, the risk that new developments in the rapidly evolving cancer therapy landscape require changes in our clinical trial plans or limit the potential benefits of our product candidates and the other factors described in our risk factors set forth in our filings with the Securities and Exchange Commission from time to time, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.

ORCA™, Borealis-1™, Borealis-2™, Spruce™, Rainier™ and Pacific™, are registered trademarks of OncoGenex Pharmaceuticals, Inc.
ABRAXANE® is a registered trademark of Celgene Corporation
JEVTANA® is a registered trademark of sanofi-aventis
Zytiga® is a registered trademark of the Johnson & Johnson Corporation

 


'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. OncoGenex Pharmaceuticals, Inc. Provides Update on Clinical Development Program and Reports Financial Results for Fourth Quarter and Year End 2012
2. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
3. OncoGenex Announces Initiation of the Phase 3 "AFFINITY" Trial for Patients with Advanced Prostate Cancer
4. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
5. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
6. Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
7. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
8. Avion Pharmaceuticals, LLC., announces further expansion of their Womens Health Sales Team
9. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
10. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
11. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 Global ... World demand for caps and closures will exceed $55 ... to exceed two trillion annually. Beverages will continue to account ... pharmaceuticals and a number of smaller markets are expected to ... advances Although the most developed markets -- the US, ...
(Date:4/21/2015)... Fla. , April 21, 2015  A new, ... the First Coast that promises to revolutionize the way ... fellowship-trained at the world-renowned Montsouris Institute in ... guided prostate biopsy in the North Florida ... this innovative technology in prostate cancer diagnosis and management ...
(Date:4/21/2015)... Fla. , April 21, 2015   Rock ... drug development company focused on the treatment of chronic ... key independent appointment to the Company,s Board of Directors ... Samuel as a new director. ... of Rock Creek Pharmaceuticals, said, "Dr. Samuel,s experience in ...
Breaking Medicine Technology:World Caps & Closures Market 2World Caps & Closures Market 3Kasraeian Urology Unveils Jacksonville's First UroNav Advanced Prostate Cancer Detection Technology 2Kasraeian Urology Unveils Jacksonville's First UroNav Advanced Prostate Cancer Detection Technology 3Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 2Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 3Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 4Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 5Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 6Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 7
(Date:4/21/2015)... Point of Care Ultrasound is an ultrasound education company ... that will enable medics to perform and Stream live ... department or a consultant's smart device. Without taking valuable ... more advanced determinations will immediately be able to made ... or internal bleeding from trauma. , We will be ...
(Date:4/21/2015)... ID (PRWEB) April 21, 2015 My ... retailer to offer the latest innovation in home water ... ultra effective filtration system that makes existing gravity-fed filters ... Pro™ surpasses federal and industry standards for water filtration. ... daily supply for a typical household. , The Alexapure ...
(Date:4/21/2015)... Henry Mayo Newhall Hospital, located in California’s Santa ... automatically send continuation of care documents (CCDs). When the ... with clinics and other ambulatory practices, they selected Summit ... , “Provider Alert will enable the physician offices we ... to provide continuing care in real time,” said Cindy ...
(Date:4/21/2015)... Rockville, MD (PRWEB) April 21, 2015 ... half describe their child’s dental health as fair or ... Dentistry. This is not surprising, as a visit to ... with autism. The sensory overload from the strange smells, ... masked adult looming; and the unpredictability of the whole ...
(Date:4/21/2015)... Top medical tourism firm, VisitandCare.com, is recognizing a ... to providing superior patient experiences. Ojas Aesthetic Clinic ... best possible experience for a comprehensive range of treatments ... at Ojas Aesthetic Clinic persistently assert that, “Ojas Aesthetic ... you, without you — through transparent engagement with the ...
Breaking Medicine News(10 mins):Health News:Preparedness Leader My Patriot Supply Unveils the New Alexapure Pro™ Water Filter 2Health News:Henry Mayo Newhall Hospital to Improve Ambulatory Information Sharing with Summit Healthcare's Summit Provider Alert 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 3Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 5Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 6Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 2Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 3
... senior authors are nationally known informatics leaders and members ... the Feb. 2010 issue of Health Affairs ... care delivery in an increasingly information-driven era of health ... critical role that information technology, and the health informatics ...
... metabolic events in bacteria that lead to fatal diseases such ... according to an article published in the February issue of ... Surrey are using this new ,systems biology, approach to try ... Mycobacterium tuberculosis which allow it to survive dormant ...
... be viable, researchers say , FRIDAY, Feb. 5 (HealthDay News) ... if they,re at risk of having children with spinal muscular ... controversy about whether screening for SMA -- the most common ... to couples. , In this study, researchers created an analytical ...
... 105 Million ... Alternative to Over-The-Counter Sleep Aids , ... Houston (PRWEB) February 5, 2010 -- Houston-based Aikon Wellness, Inc. announced today that it ... ). In a pre-market test, this natural sleep aid helped many people fall asleep ...
... ... the H1N1 influenza epidemic by facilitating easy transfer of health results to the Centers ... ... a leading provider of healthcare diagnostic information technology and outreach solutions, announced that its ...
... ... steady fixture in community well into its third decade of fighting for rights of Bucks ... Langhorne, Penn. ... Weber is celebrating its 25th anniversary of representing Bucks County residents in a wide ...
Cached Medicine News:Health News:Informatics experts contribute to special Health Affairs edition on e-health in the developing world 2Health News:Informatics experts contribute to special Health Affairs edition on e-health in the developing world 3Health News:Road mapping could be key to curing TB 2Health News:Screening for Spinal Muscular Atrophy Not Cost-Effective: Study 2Health News:Aikon Wellness Launches New Revolutionary All Natural Sleep Aid Somniac PM 2Health News:Aikon Wellness Launches New Revolutionary All Natural Sleep Aid Somniac PM 3Health News:Sunquest Information Systems Supports New Meaningful Use Guidelines for Laboratories Transferring H1N1 Results 2Health News:Sunquest Information Systems Supports New Meaningful Use Guidelines for Laboratories Transferring H1N1 Results 3Health News:Law Firm of Paul R. Weber Celebrates 25th Anniversary in Bucks County 2
Lacrimal Cannulas, 19 g. shaft tapering to 23 g. cannula, straight. Overall length 37.5 mm. 5/box....
Anterior Chamber Needle, 27 g., 5 mm from bend to tip. Overall length 22 mm. 5/box....
Anterior Chamber Needle, 25 g. Angled. 9 mm angled tip. Overall length 19 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Straight with U-tip. U-shaped tip allows aspiration and irrigation at the 12 o'clock position. Overall length 18 mm. 5/box....
Medicine Products: